Jaakko‐Juhani Himberg

A potentially hazardous interaction between erythromycin and midazolam

Klaus T. Olkkola, Kari Aranko, Harri Luurila et al. · Clinical Pharmacology & Therapeutics · 1993 · 354 citations

Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue during short-term simvastatin treatment in humans*

Reijo Laaksonen, Kalle Jokelainen, Timo Sahi et al. · Clinical Pharmacology & Therapeutics · 1995 · 177 citations

The effect of Simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscle

Reijo Laaksonen, Kalle Jokelainen, Juha Laakso et al. · The American Journal of Cardiology · 1996 · 173 citations

Simvastatin Treatment, Biochemistry, Skeletal Muscle +10

Pharmacokinetics of Midazolam Following Intravenous and Oral Administration in Patients with Chronic Liver Disease and in Healthy Subjects

P J Pentikäinen, L. Välisalmi, Jaakko‐Juhani Himberg et al. · The Journal of Clinical Pharmacology · 1989 · 135 citations

Serum ubiquinone concentrations after short- and long-term treatment with HMG-CoA reductase inhibitors

Reijo Laaksonen, Jukka-Pekka Ojala, Matti J. Tikkanen et al. · European Journal of Clinical Pharmacology · 1994 · 94 citations

Hmg-coa Reductase Inhibitors, Medicine, Serum Ubiquinone Concentrations +5